| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 11% | $1,298,658,873 | 20,620,179 | BlackRock, Inc. | 31 Mar 2025 | |||
| PRIMECAP MANAGEMENT CO/CA/ | 8.2% | $906,812,938 | 15,795,383 | PRIMECAP MANAGEMENT CO/CA/ | 30 Jun 2025 | |||
| Capital Research Global Investors | 4.8% | -29% | $576,308,252 | -$241,913,549 | 9,150,655 | -30% | Capital Research Global Investors | 31 Mar 2025 |
| VIKING GLOBAL INVESTORS LP | 4.3% | -35% | $450,729,215 | -$214,821,957 | 8,322,179 | -32% | VIKING GLOBAL INVESTORS LP | 30 Sep 2025 |
As of 30 Sep 2025, 569 institutional investors reported holding 179,374,894 shares of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN). This represents 93% of the company’s total 193,539,047 outstanding shares.
The largest institutional shareholders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) together control 65% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 11% | 22,046,050 | -8.1% | 0.02% | $1,194,014,041 |
| VANGUARD GROUP INC | 9.6% | 18,582,585 | -2.2% | 0.02% | $1,006,432,803 |
| PRIMECAP MANAGEMENT CO/CA/ | 7.9% | 15,229,287 | -3.4% | 0.63% | $824,818,238 |
| Dodge & Cox | 7.6% | 14,686,801 | -2.8% | 0.43% | $795,437,142 |
| STATE STREET CORP | 4.5% | 8,764,599 | -0.94% | 0.02% | $474,690,682 |
| VIKING GLOBAL INVESTORS LP | 4.3% | 8,322,179 | -32% | 1.2% | $450,729,215 |
| AQR CAPITAL MANAGEMENT LLC | 3.1% | 5,932,109 | +6.3% | 0.21% | $321,283,017 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8% | 3,542,120 | +1.9% | 0.01% | $191,287,006 |
| MILLENNIUM MANAGEMENT LLC | 1.4% | 2,627,210 | -7.3% | 0.11% | $142,289,694 |
| Capital Research Global Investors | 1.3% | 2,537,596 | +548% | 0.03% | $137,436,199 |
| GOLDMAN SACHS GROUP INC | 1.2% | 2,290,960 | +8.8% | 0.02% | $124,078,425 |
| DIMENSIONAL FUND ADVISORS LP | 1.2% | 2,245,186 | +43% | 0.03% | $121,596,850 |
| RENAISSANCE TECHNOLOGIES LLC | 0.98% | 1,893,571 | +4.8% | 0.14% | $102,555,805 |
| NORTHERN TRUST CORP | 0.86% | 1,662,268 | +0.43% | 0.01% | $90,028,434 |
| UBS Group AG | 0.8% | 1,540,170 | -9.2% | 0.02% | $83,415,608 |
| Man Group plc | 0.77% | 1,493,379 | +1.1% | 0.16% | $80,881,406 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.72% | 1,397,600 | -10% | 0.01% | $75,694,016 |
| Squarepoint Ops LLC | 0.72% | 1,388,524 | -17% | 0.16% | $75,202,460 |
| MORGAN STANLEY | 0.71% | 1,380,444 | -43% | 0% | $74,764,966 |
| Bank of New York Mellon Corp | 0.71% | 1,372,436 | +0.5% | 0.01% | $74,331,156 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 0.69% | 1,332,398 | +379% | 0.24% | $72,162,676 |
| DNB ASSET MANAGEMENT AS | 0.66% | 1,274,284 | +14% | 0.26% | $69,015,221 |
| AMERIPRISE FINANCIAL INC | 0.63% | 1,228,662 | -43% | 0.02% | $66,543,522 |
| DEUTSCHE BANK AG\ | 0.56% | 1,085,983 | +22% | 0.02% | $58,816,839 |
| UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC | 0.56% | 1,074,173 | -19% | 0.01% | $58,177,212 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 2,850,315 | $169,455,425 | +$81,883,717 | $59.43 | 25 |
| 2025 Q3 | 179,374,894 | $9,714,899,362 | -$262,571,560 | $54.16 | 569 |
| 2025 Q2 | 184,517,274 | $10,145,314,583 | +$90,429,124 | $54.97 | 576 |
| 2025 Q1 | 181,117,177 | $12,795,609,480 | -$83,582,224 | $70.69 | 576 |
| 2024 Q4 | 183,186,403 | $12,041,547,200 | +$135,391,046 | $65.73 | 536 |
| 2024 Q3 | 180,328,429 | $12,672,555,041 | -$377,350,661 | $70.29 | 545 |
| 2024 Q2 | 184,765,128 | $15,210,183,330 | -$88,804,857 | $82.33 | 555 |
| 2024 Q1 | 186,676,383 | $16,305,278,098 | +$52,133,744 | $87.34 | 550 |
| 2023 Q4 | 185,955,477 | $17,930,401,770 | +$422,069,685 | $96.42 | 540 |
| 2023 Q3 | 181,505,269 | $16,056,450,996 | +$288,283,093 | $88.48 | 513 |
| 2023 Q2 | 178,653,463 | $15,494,286,845 | -$55,787,524 | $86.68 | 548 |
| 2023 Q1 | 179,051,547 | $17,400,388,762 | -$352,972,540 | $97.24 | 544 |
| 2022 Q4 | 182,911,512 | $18,940,963,403 | +$57,088,463 | $103.49 | 570 |
| 2022 Q3 | 182,236,184 | $15,455,338,348 | +$265,782,383 | $84.77 | 535 |
| 2022 Q2 | 179,167,298 | $14,847,543,178 | +$141,628,422 | $82.87 | 525 |
| 2022 Q1 | 177,887,694 | $13,719,376,304 | +$56,012,733 | $77.10 | 543 |
| 2021 Q4 | 177,134,050 | $15,645,638,303 | +$125,285,951 | $88.35 | 539 |
| 2021 Q3 | 175,999,345 | $13,600,848,412 | +$49,734,828 | $77.29 | 498 |
| 2021 Q2 | 176,035,547 | $14,685,174,801 | -$129,382,414 | $83.44 | 510 |
| 2021 Q1 | 177,743,163 | $13,419,458,431 | -$323,613,922 | $75.51 | 513 |
| 2020 Q4 | 182,409,125 | $15,984,411,685 | +$294,129,377 | $87.69 | 519 |
| 2020 Q3 | 179,647,602 | $13,663,308,058 | -$318,133,163 | $76.08 | 487 |
| 2020 Q2 | 180,885,676 | $22,304,634,235 | +$749,303,824 | $123.34 | 516 |
| 2020 Q1 | 176,765,627 | $14,935,321,561 | +$286,486,516 | $84.50 | 489 |
| 2019 Q4 | 173,399,113 | $14,656,072,034 | +$53,952,753 | $84.55 | 454 |
| 2019 Q3 | 173,803,512 | $11,713,783,697 | -$329,529,601 | $67.40 | 427 |
| 2019 Q2 | 178,061,150 | $15,246,971,937 | +$229,169,981 | $85.65 | 471 |
| 2019 Q1 | 178,407,022 | $15,847,079,543 | -$79,141,968 | $88.83 | 475 |
| 2018 Q4 | 179,234,022 | $15,261,762,453 | -$186,785,701 | $85.15 | 459 |
| 2018 Q3 | 180,913,922 | $17,544,279,006 | -$163,074,756 | $96.97 | 449 |
| 2018 Q2 | 182,744,905 | $17,212,623,295 | +$242,791,323 | $94.20 | 440 |
| 2018 Q1 | 180,119,807 | $14,603,106,292 | +$188,116,053 | $81.07 | 421 |
| 2017 Q4 | 177,577,894 | $15,832,679,554 | +$224,283,938 | $89.17 | 431 |
| 2017 Q3 | 174,774,741 | $16,264,630,184 | +$327,519,029 | $93.07 | 407 |
| 2017 Q2 | 171,446,875 | $15,566,292,229 | +$225,362,433 | $90.82 | 423 |
| 2017 Q1 | 169,058,166 | $14,840,823,389 | +$900,396,515 | $87.78 | 411 |
| 2016 Q4 | 169,392,815 | $14,033,179,313 | +$56,824,379 | $82.84 | 404 |
| 2016 Q3 | 168,245,764 | $15,561,381,289 | +$820,936,102 | $92.52 | 419 |
| 2016 Q2 | 159,820,679 | $12,448,675,606 | -$243,125,240 | $77.80 | 386 |
| 2016 Q1 | 162,459,664 | $13,396,780,263 | +$49,991,390 | $82.48 | 379 |
| 2015 Q4 | 161,240,868 | $16,892,503,727 | +$165,350,997 | $104.76 | 381 |
| 2015 Q3 | 159,382,647 | $16,784,552,713 | +$116,767,806 | $105.32 | 386 |
| 2015 Q2 | 157,700,975 | $21,572,249,632 | +$147,538,663 | $136.78 | 390 |
| 2015 Q1 | 156,515,480 | $19,500,401,807 | +$1,280,160,168 | $124.62 | 374 |
| 2014 Q4 | 147,645,431 | $13,350,128,993 | +$129,533,927 | $90.40 | 338 |
| 2014 Q3 | 147,667,828 | $10,655,377,287 | +$238,496,683 | $72.16 | 312 |
| 2014 Q2 | 144,555,723 | $8,993,046,726 | -$244,244,682 | $62.21 | 319 |
| 2014 Q1 | 148,047,218 | $10,094,601,533 | +$481,416,489 | $68.21 | 309 |